Daily Alpha · Reddit
· Premarket Alpha · by Buzzberg Research
Reddit’s useful debate centered on valuation hurdles and yen-funded leverage rather than broad directional consensus.
Themes on this desk
Yen carry risk
A community thesis argued that BOJ tightening and yen appreciation could force sales of U.S. assets as carry positions unwind.
Highest engagement
by score · day changeAMD valuation concerns
AMD is argued to be overvalued at ~$514/share, with a 107x EV/trailing FCF multiple that requires 27% annual FCF growth for a decade to justify current pricing.
It’s currently trading at about 107 in terms of enterprise value over a trailing free cash flow.
Implies significant downside risk if AI demand fails to meet aggressive growth expectations or if competition erodes margins.
Watch Monitor FCF growth rates and competitive developments in the AI chip space for signs of multiple compression.
Source →Novo Nordisk valuation disconnect
Novo Nordisk trades at 11x trailing earnings, which is argued to be an overreaction to US GLP-1 price resets, implying the market is pricing in a permanent impairment.
At eleven times trailing earnings, permanent impairment is the only thesis that justifies this price.
The low multiple for a dominant pharmaceutical player may offer a significant margin of safety if the market's impairment thesis is incorrect.
Watch Monitor future GLP-1 pricing impacts on long-term profitability.
Source →